Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12582681 | Fermented milk product for administration in canids such as dogs, and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2040-09-11 | 0 | 31 |
| 12583911 | Human immunodeficiency virus GP120 binding proteins | 🖼🧊📄§ | 2026-03-24 | 2043-10-31 | 0 | 31 |
| 12582639 | Preventive, relief or therapeutic use of 2,3,5-substituted thiophene compound against gastrointestinal stromal tumor | 🖼🧊📄§ | 2026-03-24 | 2041-07-30 | 0 | 31 |
| 12582632 | Inhibition of neurological injuries due to infections via administration of Butanetap and analogs thereof | 🖼🧊📄§ | 2026-03-24 | 2042-05-17 | 0 | 31 |
| 12582626 | Methods and compositions for treating cancer | 🖼🧊📄§ | 2026-03-24 | 2042-06-07 | 0 | 31 |
| 12584147 | Rational polyploid adeno-associated virus vectors for the treatment of disease | 🖼🧊📄§ | 2026-03-24 | 2043-05-19 | 0 | 31 |
| 12583894 | Materials and methods for the treatment of Lewy body disorders | 🖼🧊📄§ | 2026-03-24 | 2039-04-03 | 0 | 31 |
| 12583892 | Conus-based toxin peptides, nucleic acids encoding same and uses thereof in modulating NMDA receptors | 🖼🧊📄§ | 2026-03-24 | 2042-06-28 | 0 | 31 |
| 12583822 | Benzylamine derivative, preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-24 | 2041-07-28 | 0 | 31 |
| 12583852 | Heterocycle derivative | 🖼🧊📄§ | 2026-03-24 | 2039-05-02 | 0 | 31 |
| 12583914 | Methods of treating allergy using anti-bet v 1 antibodies | 🖼🧊📄§ | 2026-03-24 | 2043-12-19 | 0 | 31 |
| 12584137 | Aptamers for personal health care applications | 🖼🧊📄§ | 2026-03-24 | 2042-12-14 | 0 | 31 |
| 12582682 | Probiotic compositions for the treatment of acne | 🖼🧊📄§ | 2026-03-24 | 2041-09-14 | 0 | 31 |
| 12582711 | RNA-based adjuvant to enhance the immune response to vaccines and therapeutics | 🖼🧊📄§ | 2026-03-24 | 2042-08-18 | 0 | 31 |
| 12582627 | MCT formulations for improving cognitive functions | 🖼🧊📄§ | 2026-03-24 | 2041-05-17 | 0 | 31 |
| 12584145 | Conjugate systems and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2043-04-15 | 0 | 31 |
| 12582696 | Debaryomyces species as an indicator of non-healing ulcers in Crohn's disease | 🖼🧊📄§ | 2026-03-24 | 2040-12-10 | 0 | 31 |
| 12583912 | Flavivirus cross neutralizing antibody and pharmaceutical composition | 🖼🧊📄§ | 2026-03-24 | 2041-02-04 | 0 | 31 |
| 12583837 | Solid forms comprising (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and salts thereof, and compositions comprising and methods of using the same | 🖼🧊📄§ | 2026-03-24 | 2043-01-23 | 0 | 31 |
| 12582667 | Compositions and methods to treat metastatic gastrointestinal cancer | 🖼🧊📄§ | 2026-03-24 | 2040-09-25 | 0 | 31 |
| 12582635 | Compositions and methods for treating cancer with atypical BRAF mutations | 🖼🧊📄§ | 2026-03-24 | 2038-05-15 | 0 | 31 |
| 12583921 | Targeted anti-SGLT1 avian IgY antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes | 🖼🧊📄§ | 2026-03-24 | 2043-04-26 | 0 | 31 |
| 12583918 | Therapeutic agent for urological cancer which is characterized by being administered with IL-6 inhibitor and CCR2 inhibitor in combination | 🖼🧊📄§ | 2026-03-24 | 2040-04-16 | 0 | 31 |
| 12582670 | Lignin solvation using aqueous biologically compatible buffers | 🖼🧊📄§ | 2026-03-24 | 2040-01-10 | 0 | 31 |
| 12584116 | Attenuated variant of the rift valley fever virus, composition comprising same, and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2041-06-03 | 0 | 31 |
| 12582754 | Kit and method for reduction of components in a blood-related medium | 🖼🧊📄§ | 2026-03-24 | 2041-05-06 | 0 | 31 |
| 12582723 | Polynucleotides encoding a human FKRP protein | 🖼🧊📄§ | 2026-03-24 | 2043-03-02 | 0 | 31 |
| 12583868 | JAK inhibitors and methods for synthesizing and using thereof | 🖼🧊📄§ | 2026-03-24 | 2043-03-13 | 0 | 31 |
| 12583834 | Method of treating bacterial infections and pharmaceutical composition for treating bacterial infections | 🖼🧊📄§ | 2026-03-24 | 2041-02-19 | 0 | 31 |
| 12582674 | Methods and treatment of trauma | 🖼🧊📄§ | 2026-03-24 | 2043-01-09 | 0 | 31 |
| 12582691 | Administration of Yunnan Baiyao or Xingnaojing in patients with moderate-to-severe traumatic brain injury and craniotomy | 🖼🧊📄§ | 2026-03-24 | 2042-07-12 | 0 | 31 |
| 12582705 | Composition comprising botulinum toxin or salt thereof for increasing endometrial blood flow rate | 🖼🧊📄§ | 2026-03-24 | 2040-04-28 | 0 | 31 |
| 12583915 | Methods for diagnosing cancer using anti-BAG2 antibody | 🖼🧊📄§ | 2026-03-24 | 2040-02-12 | 0 | 31 |
| 12582655 | Methods of treating disorders using CSFIR inhibitors | 🖼🧊📄§ | 2026-03-24 | 2045-10-21 | 0 | 31 |
| 12583919 | Antibodies that bind to LRP6 proteins and methods of use | 🖼🧊📄§ | 2026-03-24 | 2040-08-14 | 0 | 31 |
| 12583903 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | 🖼🧊📄§ | 2026-03-24 | 2042-06-03 | 0 | 31 |
| 12583925 | Bispecific antibodies targeting PD1 and VEGF | 🖼🧊📄§ | 2026-03-24 | 2044-09-26 | 0 | 31 |
| 12582652 | 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator | 🖼🧊📄§ | 2026-03-24 | 2044-10-25 | 0 | 31 |
| 12582704 | Food composition for improving behavioral and motor function containing aldehyde dehydrogenase for reducing aldehydes produced by oxidation of alcohol | 🖼🧊📄§ | 2026-03-24 | 2044-08-09 | 0 | 31 |
| 12582619 | Compounds, compositions, and methods for treating or ameliorating, or preventing viral infections | 🖼🧊📄§ | 2026-03-24 | 2041-03-30 | 0 | 31 |
| 12582706 | Tolerogenic antigen presenting cells | 🖼🧊📄§ | 2026-03-24 | 2040-12-11 | 0 | 31 |
| 12583882 | Equatorially modified polymer linked multimers of guansine-3′, 5′-cyclic monophosphates | 🖼🧊📄§ | 2026-03-24 | 2042-08-08 | 0 | 31 |
| 12582613 | Biomimetic, reactive oxygen species-detonable nanoclusters for antirestenotic therapy | 🖼🧊📄§ | 2026-03-24 | 2042-07-21 | 0 | 31 |
| 12583891 | Peptides and methods for the treatment of diabetes | 🖼🧊📄§ | 2026-03-24 | 2043-08-08 | 0 | 31 |
| 12582703 | Blood substitutes comprising hemoglobin and methods of making | 🖼🧊📄§ | 2026-03-24 | 2042-11-08 | 0 | 31 |
| 12583884 | 3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders | 🖼🧊📄§ | 2026-03-24 | 2039-12-18 | 0 | 31 |
| 12582689 | Use of terpenoids in the treatment or prevention of fibrotic diseases | 🖼🧊📄§ | 2026-03-24 | 2041-05-19 | 0 | 31 |
| 12583940 | Monoclonal antibody which targets TFPI | 🖼🧊📄§ | 2026-03-24 | 2040-08-28 | 0 | 31 |
| 12583856 | Inhibitors of protein kinase A | 🖼🧊📄§ | 2026-03-24 | 2042-02-01 | 0 | 31 |
| 12582599 | Methods for treatment of bladder cancer with gemcitabine | 🖼🧊📄§ | 2026-03-24 | 2042-07-07 | 0 | 31 |